Stephen Karpen
Scientific Director, Regulatory Science, Transplant Therapeutics Consortium at Critical Path Institute - Catalina Foothills, AZ, US
Stephen Karpen's Colleagues at Critical Path Institute
Emily Ph.D.
'Associate Director, Huntington''s Disease Regulatory Science Consortium (HD-RSC)'
Stephen Karpen's Contact Details
520-547-3440
Critical Path Institute
Stephen Karpen's Company Details
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple other locations. For more information, visit c-path.org and c-path.eu.